Author

Swarmistha Devi Aribam

National Agriculture and Food Research OrganizationORCID 0009-0005-3200-5732Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Assay:structural biology· 1

Frequent Co-Authors

Aoi SugiyamaiD· 1 shared Chhandosee GangulyiD· 1 shared Leonard M. ThomasiD· 1 shared Lindsie Martin· 1 shared Masahiro Eguchi· 1 shared Megumi Onishi· 1 shared Momoko NakayamaiD· 1 shared Osamu Mikami· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Aoi SugiyamaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintJan 9, 2025

Helical transition of the bridge helix of Cas12a is an allosteric regulator of R-loop formation and RuvC activation

Chhandosee Ganguly, Lindsie Martin, Swarmistha Devi Aribam…·Rakhi Rajan

This study investigates how the bridge helix (BH) of Cas12a regulates R-loop formation and RuvC activation through conformational changes, revealing structural mechanisms for improving Cas12a specificity.

DOI 10.1101/2025.01.09.632262

structural biologyexperimental assay

𝕏 PostBluesky

MicrobiologyMicrobiology SpectrumPeer-reviewedFeb 22, 2024

A novel vaccine strategy using quick and easy conversion of bacterial pathogens to unnatural amino acid-auxotrophic suicide derivatives

Yuya Nagasawa, Momoko Nakayama, Yusuke Kato…·Masahiro Eguchi

This paper introduces a method to convert bacterial pathogens into live vaccines using unnatural amino acid-auxotrophic suicide derivatives, showing enhanced immunogenicity and safety.

4 citations

E. colihuman

𝕏 PostBluesky